The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany

被引:16
作者
Gandjour, Afschin [1 ]
机构
[1] Frankfurt Sch Finance & Management, Adickesallee 32-34, D-60322 Frankfurt, Germany
关键词
COVID-19; Economic value; Germany; Shutdown;
D O I
10.1016/j.qref.2020.10.007
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background and aim: A shutdown of businesses enacted during the SARS-CoV-2 pandemic can serve different goals, e.g., preventing the intensive care unit (ICU) capacity from being overwhelmed ('flattening the curve') or keeping the reproduction number substantially below one ('squashing the curve'). The aim of this study was to determine the clinical and economic value of a shutdown that is successful in 'flattening' or 'squashing the curve' in Germany. Methods: In the base case, the study compared a successful shutdown to a worst-case scenario with no ICU capacity left to treat COVID-19 patients. To this end, a decision model was developed using, e.g., information on age-specific fatality rates, ICU outcomes, and the herd protection threshold. The value of an additional life year was borrowed from new, innovative ontological drugs, as cancer reflects a condition with a similar morbidity and mortality burden in the general population in the short term as COVID-19. Results: A shutdown that is successful in 'flattening the curve' is projected to yield an average health gain between 0.01 and 0.05 life years (0.1 to 0.6 months) per capita in the German population. The corresponding economic value ranges between (sic)616 and (sic)4797 per capita or, extrapolated to the total population, 1%-12% of the gross domestic product (GDP) in 2019. A shutdown that is successful in 'squashing the curve' is expected to yield a minimum health gain of 0.08 life years (1 month) per capita, corresponding to 19 % of the GDP in 2019. Results are particularly sensitive to mortality data and the prevalence of undetected cases. Conclusion: A successful shutdown is forecasted to yield a considerable gain in life years in the German population. Nevertheless, questions around the affordability and underfunding of other parts of the healthcare system emerge. (C) 2020 Board of Trustees of the University of Illinois. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:502 / 509
页数:8
相关论文
共 46 条
[1]  
Abele-Brehm A, 2020, BEKAMPFUNG CORONAVIR
[2]   Clinical prediction rules in community-acquired pneumonia: lies, damn lies and statistics [J].
Abers, M. S. ;
Musher, D. M. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (07) :595-596
[3]   Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009-2017 [J].
Adlhoch, Cornelia ;
Dias, Joana Gomes ;
Bonmarin, Isabelle ;
Hubert, Bruno ;
Larrauri, Amparo ;
Oliva Dominguez, Jesus A. ;
Delgado-Sanz, Concepcion ;
Brytting, Mia ;
Carnahan, AnnaSara ;
Popovici, Odette ;
Lupulescu, Emilia ;
O'Donnell, Joan ;
Domegan, Lisa ;
van Gageldonk-Lafeber, Arianne B. ;
Meijer, Adam ;
Kyncl, Jan ;
Slezak, Pavel ;
Guiomar, Raquel ;
Orta Gomes, Carlos M. ;
Popow-Kraupp, Theresia ;
Mikas, Jan ;
Staronova, Edita ;
Melillo, Jackie M. ;
Melillo, Tanya ;
Ikonen, Niina ;
Lyytikainen, Outi ;
Snacken, Rene ;
Penttinen, Pasi .
OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (11)
[4]   Long-term survival and quality of life after intensive care for patients 80 years of age or older [J].
Andersen, Finn H. ;
Flaatten, Hans ;
Klepstad, Pal ;
Romild, Ulla ;
Kvale, Reidar .
ANNALS OF INTENSIVE CARE, 2015, 5
[5]  
[Anonymous], 2020, Financial Times
[6]  
[Anonymous], 2020, SCI MAGAZINE 0331
[7]  
[Anonymous], 2020, Global Covid-19 Case Fatality Rates
[8]   Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State [J].
Arentz, Matt ;
Yim, Eric ;
Klaff, Lindy ;
Lokhandwala, Sharukh ;
Riedo, Francis X. ;
Chong, Maria ;
Lee, Melissa .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1612-1614
[9]  
Avery Christopher, 2020, NBER Working Paper Series, V27007
[10]   The Half-Cycle Correction: Banish Rather Than Explain It [J].
Barendregt, Jan J. .
MEDICAL DECISION MAKING, 2009, 29 (04) :500-502